-- 
Glaxo’s Maxinutrition Purchase Won’t Be Probed by U.K. Regulator

-- B y   E r i k   L a r s o n
-- 
2011-02-14T11:12:03Z

-- http://www.bloomberg.com/news/2011-02-14/glaxo-s-maxinutrition-purchase-won-t-be-probed-by-u-k-regulator.html
  GlaxoSmithKline Plc ’s acquisition of
Maxinutrition Group Holdings Ltd. won’t be subjected to an
antitrust review, according to the U.K. Office of Fair Trading.  “The OFT has decided, on the information currently
available to it, not to refer” the transaction to the  Competition Commission  for an investigation, the watchdog said
today in a statement.  To contact the reporter on this story:
Erik Larson in  London  at 
 elarson4@bloomberg.net .  To contact the editor responsible for this story:
Anthony Aarons at   aaarons@bloomberg.net . 